Home
About
Overview
Sharing Data
ORCID
Help
History (119)
Pastrana Rivera, Freddie
Cynomorium
Anderson, Cameron
Social and community inclusion outcomes for adults with autism with and without intellectual disability in Australia.
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
See All 119 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 2002 Jul 15; 100(2):627-34.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Cannabinoids
Cell Survival
Dose-Response Relationship, Drug
Dronabinol
Drug Evaluation, Preclinical
Humans
Leukemia, Lymphoid
Ligands
Mice
Mice, Inbred C57BL
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Receptors, Cannabinoid
Receptors, Drug
Survival Rate
Treatment Outcome
Tumor Cells, Cultured
authors with profiles
Mitzi Nagarkatti